Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 3:21 PM
Ignite Modification Date:
2025-12-24 @ 3:21 PM
NCT ID:
NCT02425592
Eligibility Criteria:
Inclusion Criteria:
* Age 30-80
* Completed MRI Fusion prostate biopsy either in the past that demonstrated Gleason 6 prostate cancer and are either currently enrolled in Active Surveillance or are interested in Active surveillance, or have completed an MRI Fusion prostate biopsy at the first visit that demonstrates Gleason 6 prostate cancer and are interested in Active Surveillance
* Diagnosed with Gleason 6 prostate cancer
* PSA \<20
* \<cT3 prostate cancer
* Ability to receive an MRI with IV gadolinium contrast
* Life expectancy \>10 years (by physician estimate)
* Understanding and willingness to provide consent
* English speaking
Exclusion Criteria:
* Received treatment for prostate cancer (hormone manipulation, surgery, radiation).
* Known metastatic disease
* High risk prostate cancer by Epstein Criteria
* Any Gleason 7 or higher prostate cancer on prostate biopsy
* Inability to receive an MRI with IV gadolinium contrast
* Life expectancy \<10 years
* Unwillingness to undergo monitoring and imaging studies
* Non-English speaking
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
30 Years
Maximum Age:
80 Years
Study:
NCT02425592
Study Brief:
Protocol Section:
NCT02425592